Torben Straight Nissen serves as Executive at Rubius Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Torben Straight Nissen has executed 5 insider transactions totaling $293.9K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jul 24, 2019 involved exercising options for 32,146 shares valued at $6.1K.
Torben Straight Nissen currently holds 2,052,450 shares of Rubius Therapeutics, Inc. (RUBY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Torben Straight Nissen has been a net seller of RUBY stock. They have purchased $0 and sold $293.9K worth of shares.
Torben Straight Nissen's most recent insider trade was on Jul 24, 2019, when they sold 32,146 shares at $0.19 per share.
Get notified when new Form 4 filings are submitted
| 175,000 |
| $0.18 |
| Discretionary |
| Apr 8, 2019 | RUBY | $42.0K | Sale | 2,100 | $20.00 | Discretionary |
| Apr 5, 2019 | RUBY | $241.9K | Sale | 12,096 | $20.00 | Discretionary |
| Apr 3, 2019 | RUBY | $10.0K | Sale | 500 | $20.00 | Discretionary |